News
LOWELL, Mass., Jan. 8, 2018 /PRNewswire/ -- Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous system (CNS) disorders ...
Ciancio J, Aquilina K. Complications associated with intrathecal drug delivery in a paediatric patient with Niemann-Pick type C. BMJ Case Rep. 2021;14(5):e241786. doi:10.1136/bcr-2021- 241786.
LOWELL, Mass., May 15, 2018 /PRNewswire/ -- Alcyone Lifesciences, Inc., a leader in disease modifying therapies for the central nervous system (CNS) through its Advanced Precision Delivery ...
Panelists discuss how intrathecal delivery of onasemnogene abeparvovec in the STEER study demonstrates statistically significant motor function improvements in older patients with SMA (ages 2-18 ...
SwanBio Therapeutics Announces New Preclinical Data Demonstrating Proof of Principle for SBT101 Gene therapy as a Potential Treatment of Adrenomyeloneuropathy ...
Use of an intrathecal drug delivery system (IDDS) was found to reduce opioid consumption at 1 year compared with comprehensive medical management (CMM) alone among patients with noncancer chronic ...
Intrathecal drug delivery versus comprehensive medical management as it may impact inpatient length of stay, readmission, and inpatient cost of care. JCO 24 , 18520-18520 (2006). DOI: 10.1200/jco.2006 ...
Writing in PNAS, a team from the University of Zurich describes work to add to the evidence on the route of delivery.The paper discusses intranasal delivery of a mouse monoclonal antibody against ...
TerSera Therapeutics LLC, a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management, ...
A study presented at the American Academy of Pain Medicine's 26th annual meeting investigated methods for reducing the estimated $1 billion spent annually on pain care treatment in the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results